His expertise and leadership are essential as we continue to industrialize our design-build-test process for drug discovery and work to bring #miniprotein medicines to patients across many diseases.
26.08.2025 14:39 — 👍 1 🔁 0 💬 0 📌 0
James has been a pivotal force in building our protein engineering approach, and as #CTO, he'll be driving the expansion of our core technology platform, integrating machine learning, synthetic biology, robotics, and large-scale data analysis to create entirely novel protein therapeutics
26.08.2025 14:39 — 👍 1 🔁 0 💬 1 📌 0
Congratulations to Dr. James Bowman on his promotion to Chief Technology Officer!
www.businesswire.com/news/home/20...
26.08.2025 14:39 — 👍 1 🔁 1 💬 1 📌 0
I am overjoyed to announce that James Bowman has been promoted to Chief Technology Officer at @aiproteins.com!
🧵👇
26.08.2025 14:17 — 👍 7 🔁 1 💬 1 📌 0
#IPISeminar alert 🔔 Friday at 2 p.m. ET, Chris Bahl of AI Proteins will share the challenges of incorporating #artificialintelligence into #proteindesign & the impact reimagined #miniproteins can have on therapeutics. Join us through the QR code or follow the Zoom link on our calendar! rb.gy/xcee9l
01.05.2025 14:08 — 👍 2 🔁 2 💬 0 📌 0
We're delighted to share that our #Founder Chris Bahl @cdbahl.bsky.social is now our CEO!
07.01.2025 14:16 — 👍 3 🔁 0 💬 0 📌 0
So, I might have ended up on the jumbotron at the Celtics game proudly wearing my @aiproteins.bsky.social colors
20.12.2024 03:17 — 👍 10 🔁 1 💬 0 📌 0
Mireia Solà Colom, Head of Immunotherapeutics at AI Proteins, presents our latest progress on the design and optimization of immune cell engagers built from our de novo #miniproteins
17.12.2024 21:26 — 👍 3 🔁 0 💬 1 📌 0
Bristol Myers Squibb taps AI Proteins in drug discovery collaboration worth up to $400M
Bristol Myers Squibb has
You can read more about our exciting new collaboration with Bristol Myers Squibb in this coverage from Fierce Biotech
www.fiercebiotech.com/biotech/bris...
03.12.2024 18:58 — 👍 3 🔁 1 💬 1 📌 0
We're excited that Mireia Solà Colom, our Head of Immunotherapeutics will share some of our latest work on immune cell engagers at @bpdmc.bsky.social next month!
25.11.2024 13:33 — 👍 3 🔁 0 💬 1 📌 0
YouTube
Share your videos with friends, family, and the world
Our founder, President and CSO Chris Bahl @cdbahl.bsky.social went to the Falling Walls Science Summit last week to explain how we make #miniprotein therapeutics with unprecedented ability to control cellular behavior - you can check out the recording 👇
www.youtube.com/live/zB6-iUB...
16.11.2024 18:25 — 👍 3 🔁 1 💬 0 📌 0
Structural basis of peptide-mediated protein communication and function @hebrewuniversity.bsky.social
Member of @rosettacommons.bsky.social
Posts by lab members.
Rosetta Commons is the central hub for hundreds of developers and scientists from ~100 universities and laboratories to contribute and share the Rosetta source code.
Rosetta Commons members develop software improvements to solve their unique queries.
We are a global community of computational protein engineers and modelers from both academia and industry.
An @omsf.io project organized by @cdbahl.com, @sokrypton.org, and @nickpolizzi.bsky.social
https://bpdmc.org
We advance protein science to accelerate research & improve human health | proteininnovation.org
A global community of researchers dedicated to the understanding of proteins.
Laboratory of Todd Fehniger at Washington University (WashU)
Immunology | NK cell biology | Cellular therapy | Blood cancers | ILCs
Saint Louis, MO, USA | fehnigerlab.org
We create proteins that solve modern challenges in medicine, technology, and sustainability.
• 2024 Nobel Prize in Chemistry
• University of Washington, Seattle
→ ipd.uw.edu
Surfing the protein design wave 🌊
Scientist made in 🇦🇷, currently in 🇺🇲
De novo protein design aficionado.
protein geek, founder and CEO of AI Proteins @aiproteins.com
https://linkedin.com/in/cdbahl
